Inpatient and Pharmacy Management

Episode 727: Dealing with and preventing negative interactions with other professionals

Pharmacy Joe

JULY 3, 2022

How I deal with negative interactions has been heavily influenced by “Pharmacy Chris.” Before graduating pharmacy school, I worked as an intern in a community pharmacy, and Chris was the pharmacy manager. One thing I noticed about Chris was that his mood was unflappable.

Physician Offices

Physician Offices Community Pharmacies Pharmacy Management Inpatient

Episode 727: Dealing with and preventing negative interactions with other professionals

Pharmacy Joe

JULY 3, 2022

How I deal with negative interactions has been heavily influenced by “Pharmacy Chris.” Before graduating pharmacy school, I worked as an intern in a community pharmacy, and Chris was the pharmacy manager. One thing I noticed about Chris was that his mood was unflappable.

Physician Offices

Physician Offices Community Pharmacies Pharmacy Management Inpatient

Four Times When My Pharmacy Had To Say “No” — And We Weren’t Just Being Difficult

The Happy PharmD

JANUARY 4, 2023

As a pharmacy manager, I got that a lot. I always felt my pharmacy department was treated like second-class citizens. The pharmacy always had to give in. . My pharmacy was a hospital pharmacy. We filled prescriptions for inpatients. “Oh, you’re just being difficult!” I don’t know.

Episode 727: Dealing with and preventing negative interactions with other professionals

Episode 727: Dealing with and preventing negative interactions with other professionals

Trending Sources

Four Times When My Pharmacy Had To Say “No” — And We Weren’t Just Being Difficult

Reinventing Transplant Care: From Inpatient Tradition to Outpatient Innovation

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Atrium Health: Pioneering Outpatient Transplant Models Driven by Pharmacist-Led Care

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology Patients

What Pharmacists Should Know About Medicare Open Enrollment 2023

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

Study: Prevalence and Clinical Implications of MASLD in Type 2 Diabetes

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

Clinical Manifestations of Acute, Chronic Graft-vs-Host Disease With PTCy in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

10 Opportunities to Leverage for Career Advancement

What Pharmacists Should Know About Medicare Open Enrollment 2024

High Response Rates With Talquetamab Plus Teclistamab in Triple-Class Refractory Multiple Myeloma

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Review Demonstrates Impaired Quality of Life in Children With Pneumococcal Disease Despite Variations in Study Methodologies

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Investigating the Pharmacist’s Role in Psychedelic-Assisted Psychotherapy for Patients With Cancer

Do We Really Pay More for Prescription Drugs in the United States?

Stay Connected